IBSA Pharma recalls TIROS: levothyroxine oral solution with subpotent drug risk. This may not provide proper thyroid hormone levels. Consumers should contact pharmacy for guidance.
Subpotent Drug
IBSA Pharma is recalling a specific levothyroxine oral solution because it may not contain enough active ingredient. This could lead to improper thyroid hormone levels in users, potentially causing health issues.
The medication may have less active levothyroxine than labeled, leading to insufficient thyroid hormone levels. This could cause symptoms like fatigue, weight gain, or depression if not properly managed.
People prescribed this medication by a doctor who received the recalled product. Those with thyroid conditions are most at risk.
Check for the product name 'TIROSINT - SOL', 75 microgram/mL concentration, 6 pouches with 5 ampules each. The NDC code 71858-0120-5 and lot number 220853 (expiring 02/2024) are also identifiers.
Talk to your healthcare provider about whether you need to switch to a different medication.
The recall states it may be subpotent, meaning it could have less active ingredient than labeled. Consult your doctor for personalized advice.
Look for the product name 'TIROSINT - SOL', 75 microgram/mL, 6 pouches x 5 ampules, NDC 71858-0120-5, and lot number 220853 (expiring 02/2024).
The recall does not specify a stop-use instruction. Contact your doctor for guidance on whether to switch medications.
We’ve drafted a message you can send IBSA Pharma to request your refund or repair — edit it as you like.
Subject: Recall D-0340-2023 — IBSA Pharma IBSA Pharma Hello, I own a IBSA Pharma that is covered by recall D-0340-2023 from IBSA Pharma. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
